This can be hypothesized based on the fact that the multivariate analysis of nonmatched patients showed an important trend toward an association between the use of dexmedetomidine and reduced RFS.
← all excerpts
Intraoperative use of dexmedetomidine is associated with decreased overall survival after lung cancer surgery.
1
—
—